Skip to content

ORINEO

Active
Private limited companyfounded 200916 yrs activeAcaciastraat 14, 3071 Kortenberg, BelgiumKBO/BCE: BE 0821.371.353
Summary

The computed 12-month bankruptcy probability of ORINEO is 2.5% (moderate). The annual accounts of ORINEO for fiscal year 2025 show a net loss of 59% of the equity at the start of that year. The 2025 annual accounts show equity of €47,066 and a net result of -€68,370. Equity is growing by ~16% per year across the filed fiscal years. Its solvency ranks better than 21% of 584 sector peers (fiscal year 2025). The company has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals.

Risk analysisWatch ReportCompare
ORINEOActiveChecked score 50/100
Risk analysis ReportCompare

Overview

Activity
Research and development on biotechnology
NACE 72101NACE 72110
Size
€394,122total assets 2025
Equity
€47,066
Loss
-€68,370
Turnover not published (abridged schema)
Financial health
50 Fair Checked score 2025
Bankruptcy chance 12 m
2.5%
Structure
Accounts on time0 of 3 deeds read
Why 50- Loss of €68,370 (FY 2025)- 2 of the last 3 late- No establishment unit in the KBO+ Size: total assets €394,122Show the evidence

Checked score

Score 2025
50 / 100
Fair
Probability in this band: 1.5% to 4.2%
Better than 14% of its sector peers (NACE 72, micro)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Weak
Solvency 37-33
equity 11.9% of total assets
Liquidity 14-47
short-term debt 80.8% · cash 6.6%
Profitability 0-72
return on assets -17.3%
Bankruptcy probability, 12 months
2.5% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (924 companies)
Last 24 months 11-2024: 1.1% 12-2024: 1.1%● 0.0% vs 11-2024 01-2025: 1.1%▼ -1.7% vs 12-2024 02-2025: 1.1%● 0.0% vs 01-2025 03-2025: 1.1%▼ -1.5% vs 02-2025 04-2025: 1.0%▼ -5.1% vs 03-2025 05-2025: 0.9%▼ -7.8% vs 04-2025 06-2025: 0.9%▼ -1.9% vs 05-2025 07-2025: 1.1%▲ +19.2% vs 06-2025 08-2025: 1.5%▲ +40.7% vs 07-2025 09-2025: 1.6%▲ +7.4% vs 08-2025 10-2025: 1.9%▲ +12.8% vs 09-2025 11-2025: 0.5%▼ -72.6% vs 10-2025 12-2025: 0.5%● 0.0% vs 11-2025 01-2026: 0.5%▼ -2.2% vs 12-2025 02-2026: 0.5%▲ +1.8% vs 01-2026 03-2026: 0.5%▼ -1.6% vs 02-2026 04-2026: 0.5%▲ +0.2% vs 03-2026 05-2026: 0.5%▼ -2.4% vs 04-2026 06-2026: 0.5%▼ -2.0% vs 05-2026 07-2026: 0.5%▼ -0.8% vs 06-2026lowest value 08-2026: 2.5%▲ +425% vs 07-2026highest value 09-2026: 2.5%● 0.0% vs 08-2026highest value 10-2026: 2.5%● 0.0% vs 09-2026highest value
  • Loss of €68,370 (FY 2025) raises the probability
  • 2 of the last 3 late raises the probability
  • Size: total assets €394,122 lowers the probability for this profile
  • No establishment unit in the KBO raises the probability
Credit up to €2,000 at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity tight (current ratio 1.2 against 1.89 in 2024; short-term debt: 80.8% and cash: 6.6% of total assets), and 88.1% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 72, micro). Better than this share of them on solvency 25%, liquidity 7%, profitability 10%, growth against the median 14%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Loss of €68,370 (FY 2025)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · 2 of the last 3 late
In the bankruptcy model this factor raises the probability.
NBB · filings
lowers risk · Size: total assets €394,122
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
raises risk · No establishment unit in the KBO
In the bankruptcy model this factor raises the probability.
KBO · seat and establishments
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 584 sector peers (2025).
NBB · sector comparison
Position among 584 sector peers
Solvency
better than 21%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
on the day
2024
68 d late
2023
31 d late
2022
31 d late
2021
30 d late
2020
30 d late
2019
94 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 41 days after the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 31 August (4 of the last 5 filed years within 31 days of that day).
Companies Code · seven months
Position in the running window
03-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Weakest financial yearnet -€68,370
  3. Annual accounts filedfiscal year 2024 · micro…

Key points

  • Caution: From profit to loss in 2025after €7,064 in 2024 -€68,370 View
  • Caution: Among the weakest 8% on net resultsector median €26,476 · 584 companies -€68,370 View
  • EU research moneyEU contribution €750,043 View

By topic

Financials

Fiscal year
2025
Total assets
€394,122
Loss
-€68,370
Solvency
11.9%
Total assets▲ 53.4%
Net result
20182025
Go to Financials

Timeline

Events
16
Since
2017
Next accounts
by 31-07-2027
  1. 31-07-2026Annual accounts filed
  2. 31-12-2025Weakest financial year
  3. 07-10-2025Annual accounts filed
Go to Timeline

Company details

Legal form
Private limited company
Activity
Research and development on biotechnologyNACE 72101
Founded
09-12-2009
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure